Unknown

Dataset Information

0

Rapid and efficient CRISPR/Cas9 gene inactivation in human neurons during human pluripotent stem cell differentiation and direct reprogramming.


ABSTRACT: The CRISPR/Cas9 system is a rapid and customizable tool for gene editing in mammalian cells. In particular, this approach has widely opened new opportunities for genetic studies in neurological disease. Human neurons can be differentiated in vitro from hPSC (human Pluripotent Stem Cells), hNPCs (human Neural Precursor Cells) or even directly reprogrammed from fibroblasts. Here, we described a new platform which enables, rapid and efficient CRISPR/Cas9-mediated genome targeting simultaneously with three different paradigms for in vitro generation of neurons. This system was employed to inactivate two genes associated with neurological disorder (TSC2 and KCNQ2) and achieved up to 85% efficiency of gene targeting in the differentiated cells. In particular, we devised a protocol that, combining the expression of the CRISPR components with neurogenic factors, generated functional human neurons highly enriched for the desired genome modification in only 5 weeks. This new approach is easy, fast and that does not require the generation of stable isogenic clones, practice that is time consuming and for some genes not feasible.

SUBMITTER: Rubio A 

PROVIDER: S-EPMC5114606 | biostudies-literature | 2016 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Rapid and efficient CRISPR/Cas9 gene inactivation in human neurons during human pluripotent stem cell differentiation and direct reprogramming.

Rubio Alicia A   Luoni Mirko M   Giannelli Serena G SG   Radice Isabella I   Iannielli Angelo A   Cancellieri Cinzia C   Di Berardino Claudia C   Regalia Giulia G   Lazzari Giovanna G   Menegon Andrea A   Taverna Stefano S   Broccoli Vania V  

Scientific reports 20161118


The CRISPR/Cas9 system is a rapid and customizable tool for gene editing in mammalian cells. In particular, this approach has widely opened new opportunities for genetic studies in neurological disease. Human neurons can be differentiated in vitro from hPSC (human Pluripotent Stem Cells), hNPCs (human Neural Precursor Cells) or even directly reprogrammed from fibroblasts. Here, we described a new platform which enables, rapid and efficient CRISPR/Cas9-mediated genome targeting simultaneously wit  ...[more]

Similar Datasets

| S-EPMC5553774 | biostudies-literature
| S-EPMC6035213 | biostudies-literature
| S-EPMC5848212 | biostudies-other
| S-EPMC5032288 | biostudies-literature
| S-EPMC7656785 | biostudies-literature
| S-EPMC5443789 | biostudies-literature
| S-EPMC5533178 | biostudies-literature
| S-EPMC5006320 | biostudies-literature
| S-EPMC5646379 | biostudies-literature
| S-EPMC4232553 | biostudies-literature